ClinVar Miner

Submissions for variant NM_005591.4(MRE11):c.846-12T>C

gnomAD frequency: 0.00003  dbSNP: rs587780145
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000115924 SCV000149833 uncertain significance not provided 2013-12-11 criteria provided, single submitter clinical testing MRE11A has been only recently described in association with cancer predisposition and the risks are not well understood. This variant is denoted MRE11A IVS8-12T>C or c.846-12T>C and consists of a T>C nucleotide substitution at the -12 position of intron 8 of the MRE11A gene. Multiple in silico prediction programs predict this variant to weaken a nearby canonical acceptor site, and to possibly cause abnormal gene splicing. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. Based on the currently available information, we consider this variant to have unknown significance.
Labcorp Genetics (formerly Invitae), Labcorp RCV002228253 SCV002509549 likely benign Ataxia-telangiectasia-like disorder 2024-10-29 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV003114261 SCV003799756 likely benign Ataxia-telangiectasia-like disorder 1 2022-03-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.